Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


ucin1085566152.pdf (1.79 MB)

ETD Abstract Container

Abstract Header

EFFICACY AND MECHANISM OF ACTION OF A NEW TYROSINASE INHIBITORY AGENT

HAMED, SAJA H.
http://rave.ohiolink.edu/etdc/view?acc_num=ucin1085566152

Abstract Details

2004, PhD, University of Cincinnati, Pharmacy : Pharmaceutical Sciences.
Acquired hyperpigmentation diseases, are common skin diseases. An example is melasma that is permanent in middle-aged women. Hyperpigmentation diseases have psychosocial and cosmetic importance since they are common on sun-exposed areas of the face and the neck. Various treatments are available in the market, but none are completely satisfactory. Most popular skin depigmenting products use a tyrosinase inhibitor as the active ingredient as a result of the key role played by tyrosinase in melanin biosynthesis. The success of these products is limited for two basic reasons: safety or overall effectiveness. Because of the need to provide a skin depigmenting agent that is more efficacious, more stable and less cytotoxic we have analyzed a novel compound, deoxyarbutin (DA). DA was synthesized based on key structure/function relationships of tyrosinase inhibitors, for its tyrosinase inhibition and depigmenting efficacy. DA demonstrated less cytotoxicity, compared to hydroquinone (HQ), in the three normal human skin cell types (i.e., melanocytes, keratinocytes and fibroblasts). This cytotoxicity was not associated with dramatic changes on the morphology of the keratinocytes as in HQ. The lower cytotoxicity of DA as compared to HQ lends support to the stability of DA, lack of auto-oxidation, and the less harmful by-products generated from its metabolism by tyrosinase and/or other metabolic routes. DA was shown in our cell based assay to effectively inhibit tyrosinase activity and melanin synthesis. DA inhibition was reversible whereas HQ showed less or no reversibility. Further, DA reversed skin hyperpigmentation of human skin grafted onto immunocompromised mice with no irritation or negative effect on the graft histology. This lightening effect didn’t reach statistical significance and the sample size is small (n=3). In addition, evidence is provided for the need to standardize the methods used to screen for new tyrosinase inhibitory agents and that MTT assay is not the viability assay of choice when assessing the effect of DA and HQ on cell viability. Based on our viability and in vivo studies, deoxyarbutin has the potential to be a safe and effective depigmenting agent and to be an effective alternative to hydroquinone; the skin depigmenting standard with known safety drawbacks.
Dr. Randall Wickett (Advisor)
147 p.
Health Sciences, Pharmacy
Deoxyarbutin; Hydroquinone; Skin depigmenting agents

Recommended Citations

Citations

  • HAMED, S. H. (2004). EFFICACY AND MECHANISM OF ACTION OF A NEW TYROSINASE INHIBITORY AGENT [Doctoral dissertation, University of Cincinnati]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1085566152

    APA Style (7th edition)

  • HAMED, SAJA. EFFICACY AND MECHANISM OF ACTION OF A NEW TYROSINASE INHIBITORY AGENT. 2004. University of Cincinnati, Doctoral dissertation. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=ucin1085566152.

    MLA Style (8th edition)

  • HAMED, SAJA. "EFFICACY AND MECHANISM OF ACTION OF A NEW TYROSINASE INHIBITORY AGENT." Doctoral dissertation, University of Cincinnati, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1085566152

    Chicago Manual of Style (17th edition)

ucin1085566152
1,891
© 2004, all rights reserved.
This open access ETD is published by University of Cincinnati and OhioLINK.